Sino Medical Sciences Technology Inc. (SHA:688108)
China · Delayed Price · Currency is CNY 23.89
-0.15 (-0.62%)
At close: Jan 23, 2026
SHA:688108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 33.53 | 1.5 | -39.63 | -162.38 | -130.77 | 22.49 | Upgrade |
Depreciation & Amortization | 76.82 | 76.82 | 62.81 | 63.17 | 65.41 | 38.3 | Upgrade |
Other Amortization | 25.74 | 25.74 | 24.55 | 24.11 | 15.48 | 7.91 | Upgrade |
Loss (Gain) From Sale of Assets | -0.29 | -0.29 | 1.41 | -0 | -0.19 | -0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 0.09 | 0.09 | 0.14 | 2.22 | 0.08 | 0.02 | Upgrade |
Loss (Gain) From Sale of Investments | -11.19 | -11.19 | 4.67 | 4.11 | 0.29 | -6.26 | Upgrade |
Provision & Write-off of Bad Debts | -0.43 | -0.43 | -1.41 | 1.33 | -0.54 | 0.48 | Upgrade |
Other Operating Activities | 20.69 | 18.47 | 5.37 | 6.78 | 11.62 | 2.02 | Upgrade |
Change in Accounts Receivable | 10.31 | 10.31 | 18.86 | 7.73 | 100.12 | -13.75 | Upgrade |
Change in Inventory | 18.7 | 18.7 | -14.53 | -18.38 | -27.79 | 3.65 | Upgrade |
Change in Accounts Payable | 0.34 | 0.34 | 3.03 | 8.04 | -59.48 | 15.26 | Upgrade |
Change in Other Net Operating Assets | 3.27 | 3.27 | 7.62 | - | - | - | Upgrade |
Operating Cash Flow | 165.49 | 131.24 | 56.84 | -111.31 | -60.13 | 70.51 | Upgrade |
Operating Cash Flow Growth | 135.36% | 130.89% | - | - | - | -48.76% | Upgrade |
Capital Expenditures | -49.31 | -70.02 | -67.67 | -110.76 | -158.45 | -112.78 | Upgrade |
Sale of Property, Plant & Equipment | 0.87 | 0.83 | 1.39 | 0.02 | 0.66 | 0.22 | Upgrade |
Cash Acquisitions | 2.03 | -20.35 | -127.05 | - | -25.84 | -8.95 | Upgrade |
Investment in Securities | - | - | - | 21.19 | -5 | -5 | Upgrade |
Other Investing Activities | -2.03 | 0.07 | 0.29 | 0.62 | 2.04 | 6.26 | Upgrade |
Investing Cash Flow | -48.44 | -89.46 | -193.04 | -88.93 | -186.59 | -120.25 | Upgrade |
Short-Term Debt Issued | - | - | - | 55.5 | 5 | - | Upgrade |
Long-Term Debt Issued | - | 141.48 | 159.5 | - | - | - | Upgrade |
Total Debt Issued | 161.38 | 141.48 | 159.5 | 55.5 | 5 | - | Upgrade |
Short-Term Debt Repaid | - | - | - | -25 | - | - | Upgrade |
Long-Term Debt Repaid | - | -93.79 | -44.68 | -16.2 | -14.4 | -1.75 | Upgrade |
Total Debt Repaid | -83.09 | -93.79 | -44.68 | -41.2 | -14.4 | -1.75 | Upgrade |
Net Debt Issued (Repaid) | 78.29 | 47.69 | 114.82 | 14.3 | -9.4 | -1.75 | Upgrade |
Issuance of Common Stock | 11.53 | 15.38 | - | 103.5 | - | - | Upgrade |
Common Dividends Paid | -4.3 | -4.11 | -2.01 | -0.94 | -0.03 | -41.33 | Upgrade |
Other Financing Activities | -69.82 | 2.51 | 9.5 | - | - | -0.04 | Upgrade |
Financing Cash Flow | 15.71 | 61.47 | 122.32 | 116.86 | -9.43 | -43.12 | Upgrade |
Foreign Exchange Rate Adjustments | -0 | -0.21 | -0.9 | -0.95 | -0.75 | -0.86 | Upgrade |
Net Cash Flow | 132.76 | 103.03 | -14.78 | -84.33 | -256.91 | -93.72 | Upgrade |
Free Cash Flow | 116.18 | 61.22 | -10.83 | -222.07 | -218.58 | -42.27 | Upgrade |
Free Cash Flow Margin | 23.05% | 13.35% | -3.16% | -115.15% | -112.46% | -12.91% | Upgrade |
Free Cash Flow Per Share | 0.28 | 0.16 | -0.03 | -0.55 | -0.54 | -0.10 | Upgrade |
Cash Income Tax Paid | 46.25 | 29.68 | 22.67 | -3.27 | 1.14 | 46.35 | Upgrade |
Levered Free Cash Flow | 101.39 | 95.15 | -29.66 | -162.62 | -163.59 | -64.37 | Upgrade |
Unlevered Free Cash Flow | 104.69 | 98.66 | -27.31 | -161.02 | -162.22 | -64.37 | Upgrade |
Change in Working Capital | 20.55 | 20.55 | -1.07 | -50.64 | -21.52 | 5.56 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.